Indeed, the serine protease inhibitors camostat and nafamostat, which interfere with S cleavage (Hoffmann et al., 2020a,b), displayed increased activity against SARS-CoV-2 infection than against SARS-CoV infection, confirming the functional relevance of the DCPs. Here, DCPS is linked to severe acute respiratory syndrome.